← Leaderboards
Samy Meroueh
Rlr Va Medical Center
$7,569,645
Attributed
$9,343,422
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,343,422 · 7
VA$0 · 1
By mechanism
R01$8,926,147 · 4
R21$416,031 · 1
P41$1,244 · 2
I01$0 · 1
Top collaborators
- Elliot J Androphy5 shared
- Thomas D. Hurley2 shared
- Fletcher A White1 shared
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructurePositioning AttributeSmall MoleculeDesignDockingProteinsSitePropertyExhibitsBiochemicalLibrariesBindingMediatingMalignant NeoplasmsCell ProliferationScreeningClinical TrialsAffinityCellsBaseSignal TransductionPharmaceutical PreparationsExpectationIn Vitro
Grant awards (26)
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection$657,376
R01 · FY2025 · CA
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection$588,858
R01 · FY2024 · CA
A Fragment-Based Strategy for K-RAS Covalent Inhibitors$462,460
R01 · FY2024 · CA · contact PI
Small Molecules to Promote Regeneration and Recovery Following Spinal Cord Injury$0
I01 · FY2024 · VA
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection$607,244
R01 · FY2023 · CA
A Fragment-Based Strategy for K-RAS Covalent Inhibitors$459,832
R01 · FY2023 · CA · contact PI
Small Molecules to Promote Regeneration and Recovery Following Spinal Cord Injury$0
I01 · FY2023 · VA · contact PI
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection$645,142
R01 · FY2022 · CA
A Fragment-Based Strategy for K-RAS Covalent Inhibitors$459,832
R01 · FY2022 · CA · contact PI
Small Molecules to Promote Regeneration and Recovery Following Spinal Cord Injury$0
I01 · FY2022 · VA · contact PI
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection$632,904
R01 · FY2021 · CA
A Fragment-Based Strategy for K-RAS Covalent Inhibitors$469,217
R01 · FY2021 · CA · contact PI
Small Molecules to Promote Regeneration and Recovery Following Spinal Cord Injury$0
I01 · FY2021 · VA · contact PI
Small-Molecule Antagonists of Ral GTPases in Cancer$586,717
R01 · FY2020 · CA · contact PI
Small-Molecule Antagonists of Ral GTPases in Cancer$569,116
R01 · FY2019 · CA · contact PI
Small-Molecule Antagonists of Ral GTPases in Cancer$586,717
R01 · FY2018 · CA · contact PI
Small-Molecule Antagonists of Ral GTPases in Cancer$590,913
R01 · FY2017 · CA · contact PI
Small-Molecule Antagonists of Ral GTPases in Cancer$602,597
R01 · FY2016 · CA · contact PI
Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe$247,971
R01 · FY2012 · CA · contact PI
Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe$247,971
R01 · FY2011 · CA · contact PI
Targeting ALDH2 for Adjuvant Treatment of Alcohol Dependence$185,031
R21 · FY2011 · AA · contact PI
Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe$255,640
R01 · FY2010 · CA · contact PI
Targeting ALDH2 for Adjuvant Treatment of Alcohol Dependence$231,000
R21 · FY2010 · AA · contact PI
Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe$255,640
R01 · FY2009 · CA · contact PI
A WEB INTERFACE FOR SCORING IN COMPUTATIONAL DRUG DESIGN$771
P41 · FY2009 · RR · contact PI
A WEB INTERFACE FOR SCORING IN COMPUTATIONAL DRUG DESIGN$473
P41 · FY2008 · RR · contact PI